Cite
Pathways implicated in tadalafil amelioration of duchenne muscular dystrophy
MLA
De Arcangelis, Valeria, et al. Pathways Implicated in Tadalafil Amelioration of Duchenne Muscular Dystrophy. Jan. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....3635e780d729d8158041efa05ecc6241&authtype=sso&custid=ns315887.
APA
De Arcangelis, V., Strimpakos, G., Gabanella, F., Corbi, N., Luvisetto, S., Magrelli, A., Onori, A., Passananti, C., Pisani, C., Rome, S., Severini, C., Naro, F., Mattei, E., Di Certo, M. G., & Monaco, L. (2016). Pathways implicated in tadalafil amelioration of duchenne muscular dystrophy.
Chicago
De Arcangelis, Valeria, Georgios Strimpakos, Francesca Gabanella, Nicoletta Corbi, Siro Luvisetto, Armando Magrelli, Annalisa Onori, et al. 2016. “Pathways Implicated in Tadalafil Amelioration of Duchenne Muscular Dystrophy,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....3635e780d729d8158041efa05ecc6241&authtype=sso&custid=ns315887.